Market Place
Sourcing Support
Candid Therapeutics & EpimAb Collaborate on T-Cell Engagers
16 Dec 2024 //
BUSINESSWIRE
EpimAb to Present Late-breaking Abstract on Preclinical Results of EMB-07
05 Mar 2024 //
BUSINESSWIRE
EpimAb to Present a Late-Breaking Abstract of First-in-Human Data of EMB-06
31 Oct 2023 //
BUSINESSWIRE
EpimAb Biotherapeutics & Almirall Announce Bispecific Antibody License Agreement
12 Oct 2023 //
BUSINESSWIRE
EpimAb to Present Initial First-in-human Data of EMB-02 at Conference
20 Sep 2023 //
BUSINESSWIRE
EpimAb to Present Initial Data of EMB-02 at the 2023 ESMO Conference
19 Sep 2023 //
BUSINESSWIRE
EpimAb Biotherapeutics Appoints Yonghong Zhu as Chief Medical Officer
07 Jun 2023 //
BUSINESSWIRE
FDA Clears EpimAb`s IND for PIb/II Trial of EMB-01 + Tagrisso for NSCLC
07 Jun 2022 //
BUSINESSWIRE
EpimAb Strengthens Scientific Advisory Board with Addition of Andrew X. Zhu
11 Oct 2021 //
BUSINESSWIRE
EpimAb Biotherapeutics Provides Clinical Update for EMB-02 and EMB-06
07 Jul 2021 //
BUSINESSWIRE
EpimAb Raises $120M in Series C Financing to Advance Bispecific Programs
23 Mar 2021 //
BUSINESSWIRE
EpimAb reels in $120M to propel 3 clinical-stage bispecifics
22 Mar 2021 //
FIERCEBIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.